OPTIMAL 2-STAGE DESIGNS FOR PHASE-II CLINICAL-TRIALS

被引：3036
作者：
SIMON, R
机构：
来源：
CONTROLLED CLINICAL TRIALS | 1989年 / 10卷 / 01期
关键词：
D O I：
10.1016/0197-2456(89)90015-9
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1 / 10
页数：10
相关论文
共 15 条
[1]  
CHANG MN, 1986, CONTROL CLIN TRIALS, V7, P18, DOI 10.1016/0197-2456(86)90004-8
[2]   DESIGNS FOR GROUP SEQUENTIAL PHASE-II CLINICAL-TRIALS [J].
CHANG, MN ;
THERNEAU, TM ;
WIEAND, HS ;
CHA, SS .
BIOMETRICS, 1987, 43 (04) :865-874
[3]   2-STAGE PLANS COMPARED WITH FIXED-SAMPLE SIZE AND WALD SPRT PLANS [J].
COLTON, T ;
MCPHERSON, K .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1976, 71 (353) :80-86
[4]   STOPPING GUIDELINES VS STOPPING RULES - A PRACTITIONERS POINT OF VIEW [J].
DEMETS, DL .
COMMUNICATIONS IN STATISTICS-THEORY AND METHODS, 1984, 13 (19) :2395-2417
[5]   ONE-SAMPLE MULTIPLE TESTING PROCEDURE FOR PHASE-II CLINICAL-TRIALS [J].
FLEMING, TR .
BIOMETRICS, 1982, 38 (01) :143-151
[6]   DETERMINATION OF NUMBER OF PATIENTS REQUIRED IN A PRELIMINARY AND A FOLLOW-UP TRIAL OF A NEW CHEMOTHERAPEUTIC AGENT [J].
GEHAN, EA .
JOURNAL OF CHRONIC DISEASES, 1961, 13 (04) :346-&
[7]   PREDICTIVE PROBABILITY EARLY TERMINATION PLANS FOR PHASE-II CLINICAL-TRIALS [J].
HERSON, J .
BIOMETRICS, 1979, 35 (04) :775-783
[8]   EFFICIENT GROUP SEQUENTIAL-TESTS WITH UNPREDICTABLE GROUP SIZES [J].
JENNISON, C .
BIOMETRIKA, 1987, 74 (01) :155-165
[9]  
JENNISON C, 1983, TECHNOMETRICS, V25, P49
[10]  
LEE YJ, 1979, CANCER TREAT REP, V63, P1721
12